Cisplatin nephrotoxicity as a model of chronic kidney disease.

scientific article published in June 2018

Cisplatin nephrotoxicity as a model of chronic kidney disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1104333900
P356DOI10.1038/S41374-018-0063-2
P932PMC publication ID6528473
P698PubMed publication ID29858580

P50authorOrson W MoeQ87611844
Ming Chang HuQ88663862
P2093author name stringMingjun Shi
Junxia Wu
Brianna Flores
Nancy Gillings
Kathryn L McMillan
P2860cites workSuppression of aging in mice by the hormone KlothoQ24650916
The aging kidney: increased susceptibility to nephrotoxicityQ26824198
Alpha Klotho and phosphate homeostasisQ26825471
Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysisQ26851216
Klotho and phosphate are modulators of pathologic uremic cardiac remodelingQ27342649
Chronic Kidney Disease, Gender, and Access to Care: A Global PerspectiveQ30234394
Acute Kidney Injury in Western CountriesQ30240194
World incidence of AKI: a meta-analysisQ30410807
Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic reviewQ33403723
The late histologic findings in diarrhea-associated hemolytic uremic syndromeQ33503373
FGF23 induces left ventricular hypertrophyQ34028891
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubuleQ34072230
Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in miceQ34103499
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survivalQ34112716
Klotho deficiency causes vascular calcification in chronic kidney diseaseQ34457281
Mitochondrial dysregulation and protection in cisplatin nephrotoxicityQ34762287
Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in ratsQ34894354
The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibodyQ35022247
Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protectiveQ35611229
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factorsQ35958459
Gender differences in hypertension and kidney diseaseQ36065332
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.Q36104887
Drug-induced acute kidney injury in childrenQ36125552
Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1Q36620380
Repeated administration of low-dose cisplatin in mice induces fibrosisQ36698742
Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.Q36746084
Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signalingQ36796604
Long-term nephrotoxicity in adult survivors of childhood cancerQ36910939
Long-Term Renal Outcomes after Cisplatin TreatmentQ37069974
Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than femaleQ37316465
Phosphate levels and cardiovascular disease in the general populationQ37474054
Risk factors of gender for renal progression in patients with early chronic kidney diseaseQ37605595
Klotho has dual protective effects on cisplatin-induced acute kidney injuryQ37678608
Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging.Q37715514
The influence of gender and sexual hormones on incidence and outcome of chronic kidney diseaseQ37902094
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular riskQ38009044
Klotho as a potential biomarker and therapy for acute kidney injuryQ38016065
The role of phosphate in kidney diseaseQ38793054
Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.Q38851203
Potential application of klotho in human chronic kidney diseaseQ39003568
Epidemiology of acute kidney injury in the intensive care unitQ39657598
Methods of reduction of cisplatin nephrotoxicity.Q40128271
CD4 T cell knockout does not protect against kidney injury and worsens cancerQ40260014
Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial functionQ41014338
αKlotho Mitigates Progression of AKI to CKD through Activation of AutophagyQ42123327
Age-dependent role of microvascular endothelial and polymorphonuclear cells in lipopolysaccharide-induced acute kidney injury.Q42507066
Phosphate and CVD: it's all in what's on the tableQ43102878
The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.Q46891097
Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal studyQ48163446
Cisplatin nephrotoxicity in rats: defect in papillary hypertonicityQ49120119
Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats.Q51114166
Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.Q51164635
Incidence and outcomes in acute kidney injury: a comprehensive population-based study.Q51765594
Developing better mouse models to study cisplatin-induced kidney injury.Q53154188
Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.Q53289364
Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor?Q55027071
Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats.Q55072805
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.Q55442487
Atubular glomeruli in cisplatin-induced chronic interstitial nephropathy. An experimental stereological investigationQ68668714
Nephrotoxicity of cisplatin in ratsQ69784982
Cis-diamminedichlorplatinum-induced acute renal failure in the ratQ70676375
Lack of age-dependent cisplatin nephrotoxicityQ70791012
Age differences in cisplatinum nephrotoxicityQ70797817
Plasma platinum levels: relationship to cisplatin dose and nephrotoxicityQ71228108
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease StudyQ80212537
Epidemiology of acute kidney injuryQ80541404
Increased risk of death and de novo chronic kidney disease following reversible acute kidney injuryQ82891406
Yes, AKI truly leads to CKDQ83880177
Self-eating for death or survival during cisplatin nephrotoxicity?Q84716943
Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in RatsQ89798733
Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterationsQ93606695
P433issue8
P1104number of pages17
P304page(s)1105-1121
P577publication date2018-06-01
P1433published inLaboratory InvestigationQ6467260
P1476titleCisplatin nephrotoxicity as a model of chronic kidney disease
P478volume98

Reverse relations

cites work (P2860)
Q90162033Cardiac Remodeling in Chronic Kidney Disease
Q90055591Evaluation of the Protective Effect of Cystone Against Cisplatin-induced Nephrotoxicity in Patients with Cancer: A Pilot Study
Q99711241High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis
Q92668491Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia
Q92940669Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury

Search more.